T-Knife Therapeutics

Biotechnology

T-Knife Therapeutics is a private biotechnology company. It has raised $110 million across 1 recorded round; the latest was an $110 million Series B in Aug 2021.

PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$110.0M
Last round
Later Stage VC (Series B)
Aug 2021
How much has T-Knife Therapeutics raised?
$110.0Macross 1 recorded rounds · Aug 2021 – Aug 2021

Most recently, T-Knife Therapeutics raised $110.0M in its Later Stage VC (Series B) (Aug 2021).

Free account
More of T-Knife Therapeutics with a free account
  • ·Watch T-Knife Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

T-Knife Therapeutics round by round

1 rounds
Aug 2021Later Stage VC (Series B)$110.0M▮
+ 2 more investors · free account

How much has T-Knife Therapeutics raised?

T-Knife Therapeutics has raised $110 million across 1 recorded round since 2021. The largest was an $110 million Series B in Aug 2021.

Frequently asked about T-Knife Therapeutics

How much has T-Knife Therapeutics raised?
T-Knife Therapeutics has raised $110.0M in total across 1 recorded funding rounds.
When was T-Knife Therapeutics's last funding round?
T-Knife Therapeutics's most recent recorded round was Later Stage VC (Series B) in Aug 2021, raising $110.0M.